BISTTRY14:34Live
ECILC Balance Sheet and Financial StatementsEis Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş.
Star MarketChemicals, Petroleum, Rubber and Plastics
43.901.20 (2.81%)
- Volume
- TRY 169M
- Day range
- 40.70 – 43.98
- Previous close
- 42.70
- Market cap
- TRY 30.1B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for ECILC is 2026/9. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Eis Eczacıbaşı İlaç Sınai ve Finansal Yatırımlar Sanayi ve Ticaret A.Ş. (ECILC), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/9 | 2.7B | 165.1M | −645.3M |
| 2026/6 | 2.4B | −84.3M | −930.9M |
| 2026/3 | 2.7B | −115.5M | −924M |
| 2025/12 | 906.9M | 378.3M | −738M |
| 2025/9 | 3.2B | 114.5M | 785M |
Frequently Asked Questions
How much profit did ECILC report in its latest statements?
In the latest period (2026/9) ECILC reported a net profit of TRY −645.3M, sales of TRY 2.7B and EBITDA of TRY 165.1M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.